Arnold I R, Mistry R, Barnett D B
Department of Clinical Pharmacology, Leicester Royal Infirmary, UK.
Eur J Pharmacol. 1993 May 15;245(3):285-9. doi: 10.1016/0922-4106(93)90109-m.
There is now evidence from human studies to suggest that cardiac beta-adrenoceptor density and coupling to adenylate cyclase may be regulated in a subtype selective fashion. An animal model was used to investigate this further. Rats were infused for 6 days with the non-selective full agonist isoprenaline (n = 6) or the beta 1-selective partial agonist xamoterol (n = 6) with sham operated rats (n = 6) for control. beta-Adrenoceptor subtype density and coupling to adenylate cyclase were determined in left ventricular membranes. Isoprenaline infusion downregulated both beta 1- (30%) and beta 2- (63%) adrenoceptor subtypes with associated reduction in adenylate cyclase stimulation through both subtypes. Xamoterol did not downregulate either subtype, but selectively uncoupled beta 1-adrenoceptors. beta 1- and total beta-adrenoceptor-mediated stimulation of adenylate cyclase was reduced less by xamoterol than isoprenaline. We conclude that coupling of rat cardiac beta-adrenoceptors can be regulated in a subtype selective fashion and that the partial agonist xamoterol does not desensitise beta-adrenoceptor mediated stimulation of adenylate cyclase to the same extent as the full agonist isoprenaline.
目前来自人体研究的证据表明,心脏β-肾上腺素能受体密度及其与腺苷酸环化酶的偶联可能以亚型选择性方式受到调节。为此使用了一种动物模型进行进一步研究。将大鼠分为三组,每组6只,其中一组连续6天输注非选择性完全激动剂异丙肾上腺素,另一组连续6天输注β1选择性部分激动剂扎莫特罗,还有一组为假手术大鼠作为对照。测定左心室膜中的β-肾上腺素能受体亚型密度及其与腺苷酸环化酶的偶联情况。输注异丙肾上腺素可使β1(30%)和β2(63%)肾上腺素能受体亚型下调,同时通过这两种亚型刺激腺苷酸环化酶的能力也相应降低。扎莫特罗不会下调任何一种亚型,但会选择性地使β1肾上腺素能受体解偶联。扎莫特罗对β1和总β肾上腺素能受体介导的腺苷酸环化酶刺激的降低程度小于异丙肾上腺素。我们得出结论,大鼠心脏β-肾上腺素能受体的偶联可以以亚型选择性方式进行调节,并且部分激动剂扎莫特罗对β-肾上腺素能受体介导的腺苷酸环化酶刺激的脱敏程度不如完全激动剂异丙肾上腺素。